drugset / Trial / NCT05289921
To Evaluate HU-014 in the Treatment of Post Stroke Upper Limb
RandomizedParallel-groupSingle-blindTreatment
Summary
Investigational Product: LIZTOX inj 100unit(HU-014) Title : Multi Center, Phase III Clinical Trial to Evaluate the efficacy and Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D Objective : To evaluate the efficacy and safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity
Timeline
- Start
- 2022-03-04
- Primary completion
- 2023-01-03
- Completion
- 2023-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HU-014 | Unknown | 360 iu | Intramuscular |
Indications
No indication recorded.